These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1041 related items for PubMed ID: 23733161

  • 1. The microRNA-218 and ROBO-1 signaling axis correlates with the lymphatic metastasis of pancreatic cancer.
    He H, Di Y, Liang M, Yang F, Yao L, Hao S, Li J, Jiang Y, Jin C, Fu D.
    Oncol Rep; 2013 Aug; 30(2):651-8. PubMed ID: 23733161
    [Abstract] [Full Text] [Related]

  • 2. Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas.
    Mees ST, Mardin WA, Sielker S, Willscher E, Senninger N, Schleicher C, Colombo-Benkmann M, Haier J.
    Ann Surg Oncol; 2009 Aug; 16(8):2339-50. PubMed ID: 19475450
    [Abstract] [Full Text] [Related]

  • 3. Vascular endothelial growth factor-D induces lymphangiogenesis and lymphatic metastasis in models of ductal pancreatic cancer.
    Von Marschall Z, Scholz A, Stacker SA, Achen MG, Jackson DG, Alves F, Schirner M, Haberey M, Thierauch KH, Wiedenmann B, Rosewicz S.
    Int J Oncol; 2005 Sep; 27(3):669-79. PubMed ID: 16077915
    [Abstract] [Full Text] [Related]

  • 4. MicroRNA-10b is overexpressed in pancreatic cancer, promotes its invasiveness, and correlates with a poor prognosis.
    Nakata K, Ohuchida K, Mizumoto K, Kayashima T, Ikenaga N, Sakai H, Lin C, Fujita H, Otsuka T, Aishima S, Nagai E, Oda Y, Tanaka M.
    Surgery; 2011 Nov; 150(5):916-22. PubMed ID: 22018284
    [Abstract] [Full Text] [Related]

  • 5. EP300--a miRNA-regulated metastasis suppressor gene in ductal adenocarcinomas of the pancreas.
    Mees ST, Mardin WA, Wendel C, Baeumer N, Willscher E, Senninger N, Schleicher C, Colombo-Benkmann M, Haier J.
    Int J Cancer; 2010 Jan 01; 126(1):114-24. PubMed ID: 19569050
    [Abstract] [Full Text] [Related]

  • 6. miRNA expression in breast cancer varies with lymph node metastasis and other clinicopathologic features.
    Wang B, Li J, Sun M, Sun L, Zhang X.
    IUBMB Life; 2014 May 01; 66(5):371-7. PubMed ID: 24846313
    [Abstract] [Full Text] [Related]

  • 7. Epithelial-to-mesenchymal transition (EMT) in intraductal papillary mucinous neoplasm (IPMN) is associated with high tumor grade and adverse outcomes.
    Lahat G, Lubezky N, Loewenstein S, Nizri E, Gan S, Pasmanik-Chor M, Hayman L, Barazowsky E, Ben-Haim M, Klausner JM.
    Ann Surg Oncol; 2014 Dec 01; 21 Suppl 4():S750-7. PubMed ID: 25069861
    [Abstract] [Full Text] [Related]

  • 8. MicroRNA expression signatures in intraductal papillary mucinous neoplasm of the pancreas.
    Lubezky N, Loewenstein S, Ben-Haim M, Brazowski E, Marmor S, Pasmanik-Chor M, Oron-Karni V, Rechavi G, Klausner JM, Lahat G.
    Surgery; 2013 May 01; 153(5):663-72. PubMed ID: 23305591
    [Abstract] [Full Text] [Related]

  • 9. Methylation-mediated silencing of the miR-124 genes facilitates pancreatic cancer progression and metastasis by targeting Rac1.
    Wang P, Chen L, Zhang J, Chen H, Fan J, Wang K, Luo J, Chen Z, Meng Z, Liu L.
    Oncogene; 2014 Jan 23; 33(4):514-24. PubMed ID: 23334332
    [Abstract] [Full Text] [Related]

  • 10. MiR-126 acts as a tumor suppressor in pancreatic cancer cells via the regulation of ADAM9.
    Hamada S, Satoh K, Fujibuchi W, Hirota M, Kanno A, Unno J, Masamune A, Kikuta K, Kume K, Shimosegawa T.
    Mol Cancer Res; 2012 Jan 23; 10(1):3-10. PubMed ID: 22064652
    [Abstract] [Full Text] [Related]

  • 11. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
    Li DD, Fu ZQ, Lin Q, Zhou Y, Zhou QB, Li ZH, Tan LP, Chen RF, Liu YM.
    World J Gastroenterol; 2015 Aug 21; 21(31):9348-57. PubMed ID: 26309360
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Identification of the differentially expressed genes between primary breast cancer and paired lymph node metastasis through combining mRNA differential display and gene microarray].
    Feng YM, Gao G, Zhang F, Chen H, Wan YF, Li XQ.
    Zhonghua Yi Xue Za Zhi; 2006 Oct 24; 86(39):2749-55. PubMed ID: 17199993
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Gene expression analysis of pancreatic cell lines reveals genes overexpressed in pancreatic cancer.
    Alldinger I, Dittert D, Peiper M, Fusco A, Chiappetta G, Staub E, Lohr M, Jesnowski R, Baretton G, Ockert D, Saeger HD, Grützmann R, Pilarsky C.
    Pancreatology; 2005 Oct 24; 5(4-5):370-9. PubMed ID: 15983444
    [Abstract] [Full Text] [Related]

  • 16. MicroRNA-301a-3p promotes pancreatic cancer progression via negative regulation of SMAD4.
    Xia X, Zhang K, Cen G, Jiang T, Cao J, Huang K, Huang C, Zhao Q, Qiu Z.
    Oncotarget; 2015 Aug 28; 6(25):21046-63. PubMed ID: 26019136
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. MicroRNAs as diagnostic markers for pancreatic ductal adenocarcinoma and its precursor, pancreatic intraepithelial neoplasm.
    Xue Y, Abou Tayoun AN, Abo KM, Pipas JM, Gordon SR, Gardner TB, Barth RJ, Suriawinata AA, Tsongalis GJ.
    Cancer Genet; 2013 Jun 28; 206(6):217-21. PubMed ID: 23933230
    [Abstract] [Full Text] [Related]

  • 20. Downregulation of miR-132 by promoter methylation contributes to pancreatic cancer development.
    Zhang S, Hao J, Xie F, Hu X, Liu C, Tong J, Zhou J, Wu J, Shao C.
    Carcinogenesis; 2011 Aug 28; 32(8):1183-9. PubMed ID: 21665894
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 53.